If you have questions about this opportunity, please contact Investor Relations (investorrelations@portfolia.com) or book a call.
Portfolia is the most active investor in women's health in the US, with 60+ investments in fast-growth women’s health companies, from seed stage to pre-IPO. Investments include early-stage companies like Bone Health(osteopenia) and Your Choice (the first male birth control pill) to fast scaling brand-name companies, like unicorns Everly Health and Maven Clinic. The Portfolia Women’s Health Fund IV builds on Portfolia’s global brand in women's health, optimizing returns and enhancing the health and wellness of women globally.
Portfolia raised the world's first venture capital fund focused exclusively in women's health in 2018, and has the most robust pipeline of investment opportunities in the field. We are the experts in scaling women’s health companies, for outsized returns and impact. McKinsey has sized the investment opportunity in women’s health at $1 trillion dollars. Portfolia Funds are best positioned to continue to lead in selecting and growing the innovative companies in women’s health for the world.